From AI Platform to the Clinic: Making the Decisions That Change a Biotech
Ürünler eklenemedi
Sepete ekleme başarısız oldu.
İstek Listesine ekleme başarısız oldu.
İstek listesinden kaldırma başarısız oldu.
Kütüphaneye ekleme başarısız oldu
Podcast takip edilemedi
Podcast takibi bırakma başarısız oldu.
From AI Platform to the Clinic: Making the Decisions That Change a Biotech
-
Seslendiren:
-
Yazan:
What happens when a biotech company realises that its next stage of growth requires a completely different approach?
In this episode of She Leads Biotech, I'm joined by Beverley Carr, Chief Business and Operating Officer at CHARM Therapeutics, to explore the realities of transforming promising science into a clinical-stage business.
Beverley shares the decisions behind CHARM's shift from a broad AI drug discovery platform to a focused oncology programme, the challenges of restructuring a business for its next stage, and why having the right people in place matters just as much as having great science.
We also discuss the real value of AI in drug discovery, the importance of making difficult decisions early, and Beverley's own journey from chemistry to biotech leadership.
It's a conversation about adaptability, courage and recognising when the path forward requires doing things differently.
Because sometimes the most important leadership decision isn't what to pursue next, but what you're prepared to leave behind.
🎧 Listen now on She Leads Biotech.
#SheLeadsBiotech #BiotechLeadership #WomenInBiotech #DrugDiscovery #LifeSciences